NeuroSense Therapeutics reports Phase 2b trial results of PrimeC in ALS

Avacta opens Phase 1 trial for AVA6103 cancer therapy in US

Imfinzi approved in EU for perioperative treatment of early gastric and gastroesophageal cancers

LynxKite Technologies expands Biophytis collaboration

BioDlink named 'Emerging CDMO of the Year' at Asia-Pacific Biopharma Excellence Awards

Vimgreen Pharmaceuticals receives IND clearance for VG081821 in China

Emerald Clinical Trials honoured with 2026 Asia Pacific Biopharma Excellence Award

Inimmune reports dosing of first patient in Phase 2 allergen challenge chamber trial of INI-2004

WuXi Biologics wins at 2026 Asia-Pacific Biopharma Excellence Awards for leadership in bioprocessing, manufacturing excellence, and digital innovation

Precision for Medicine opens new Japan office

Gesynta Pharma doses first patient in vipoglanstat Phase 2 clinical proof-of-concept trial

Avene partners with BotDesign to advance clinical studies in dermo-cosmetics

AnaCardio secures US patent for AC01, extending protection until 2042

Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026

Curatis and Neupharma partner to develop corticorelin for peritumoral brain edema in Japan